Benitec Biopharma (BNTC)

• Market cap: $400M
• 1 day: -0.6%
• 5 days: -3.79%
• 1 month: 10.5%
• 3 months: 2.64%
• 6 months: -16.51%
• Year to date: -7.23%
• 1 year: -24.74%
• 5 years: -78.19%
• 10 years: -97.38%
• Sector: Healthcare
• Industry: Biotechnology

About: Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Employees: 19